80 related articles for article (PubMed ID: 1695702)
1. The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma.
Fiedler W; Weh HJ; Suciu E; Wittlief C; Stocking C; Hossfeld DK
Leukemia; 1990 Jul; 4(7):462-5. PubMed ID: 1695702
[TBL] [Abstract][Full Text] [Related]
2. In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma.
Portier M; Rajzbaum G; Zhang XG; Attal M; Rusalen C; Wijdenes J; Mannoni P; Maraninchi D; Piechaczyk M; Bataille R
Eur J Immunol; 1991 Jul; 21(7):1759-62. PubMed ID: 2060582
[TBL] [Abstract][Full Text] [Related]
3. Clonal rearrangement of the beta-T cell receptor gene in multiple myeloma.
Berenson J; Lichtenstein A
Leukemia; 1989 Feb; 3(2):133-6. PubMed ID: 2536128
[TBL] [Abstract][Full Text] [Related]
4. Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop.
Jernberg-Wiklund H; Pettersson M; Carlsson M; Nilsson K
Leukemia; 1992 Apr; 6(4):310-8. PubMed ID: 1588793
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells.
Hata H; Xiao H; Petrucci MT; Woodliff J; Chang R; Epstein J
Blood; 1993 Jun; 81(12):3357-64. PubMed ID: 8507873
[TBL] [Abstract][Full Text] [Related]
6. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
7. Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines.
Thalmeier K; Meissner P; Reisbach G; Hültner L; Mortensen BT; Brechtel A; Oostendorp RA; Dörmer P
Exp Hematol; 1996 Jan; 24(1):1-10. PubMed ID: 8536785
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism.
Goto H; Shimazaki C; Tatsumi T; Yamagata N; Fujita N; Tsuchiya M; Koishihara Y; Ohsugi Y; Nakagawa M
Leukemia; 1995 Apr; 9(4):711-8. PubMed ID: 7723407
[TBL] [Abstract][Full Text] [Related]
9. Chromosome mapping and expression of the human interleukin-13 receptor.
Guo J; Apiou F; Mellerin MP; Lebeau B; Jacques Y; Minvielle S
Genomics; 1997 May; 42(1):141-5. PubMed ID: 9177784
[TBL] [Abstract][Full Text] [Related]
10. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS;
Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of T-cell receptor transcripts in a human T-cell leukemia bearing a t(1;14) and an inv(7); cell surface expression of a TCR-beta chain in the absence of alpha chain.
Bernard O; Groettrup M; Mugneret F; Berger R; Azogui O
Leukemia; 1993 Oct; 7(10):1645-53. PubMed ID: 8412327
[TBL] [Abstract][Full Text] [Related]
12. [Determination of interleukin-6 messenger RNA as malignant progression index in monoclonal gammapathy of undetermined significance].
Mancini R; Palange M; Dionisi MG; De Angelis V; Matteocci A; Strano L
Recenti Prog Med; 1999 Oct; 90(10):522-6. PubMed ID: 10592737
[TBL] [Abstract][Full Text] [Related]
13. New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
Stella F; Pedrazzini E; Rodríguez A; Baialardo E; Kusminsky G; Arbelbide J; Fantl DB; Slavutsky I
Cytogenet Genome Res; 2011; 134(4):249-59. PubMed ID: 21734361
[TBL] [Abstract][Full Text] [Related]
14. Role of interleukin 16 in multiple myeloma.
Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 receptor expression and saturation on the bone marrow cells of patients with multiple myeloma.
Brown RD; Gorenc B; Gibson J; Joshua D
Leukemia; 1993 Feb; 7(2):221-5. PubMed ID: 8426476
[TBL] [Abstract][Full Text] [Related]
16. Status of kappa L chain gene rearrangements and c-kit and IL-7 receptor expression in stromal cell-dependent pre-B cells.
Henderson AJ; Narayanan R; Collins L; Dorshkind K
J Immunol; 1992 Sep; 149(6):1973-9. PubMed ID: 1381391
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
Jernberg H; Pettersson M; Kishimoto T; Nilsson K
Leukemia; 1991 Mar; 5(3):255-65. PubMed ID: 1707469
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
Westendorf JJ; Ahmann GJ; Greipp PR; Witzig TE; Lust JA; Jelinek DF
Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685
[TBL] [Abstract][Full Text] [Related]
19. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.
Lum LG; Joshi ID; Smith MR; Ratanatharathorn V; Galoforo SC; Karanes C; Uberti JP; Sensenbrenner LL
Bone Marrow Transplant; 1994 Feb; 13(2):187-95. PubMed ID: 8205088
[TBL] [Abstract][Full Text] [Related]
20. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor.
Lust JA; Donovan KA; Kline MP; Greipp PR; Kyle RA; Maihle NJ
Cytokine; 1992 Mar; 4(2):96-100. PubMed ID: 1633265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]